Cardlytics, Inc.
CDLX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $52 | $63 | $62 | $74 |
| % Growth | -17.7% | 2.2% | -16.4% | – |
| Cost of Goods Sold | $28 | $34 | $37 | $41 |
| Gross Profit | $24 | $29 | $25 | $33 |
| % Margin | 46.7% | 46.3% | 40.6% | 44.2% |
| R&D Expenses | $9 | $11 | $12 | $10 |
| G&A Expenses | $11 | $13 | $14 | $14 |
| SG&A Expenses | $19 | $24 | $27 | $25 |
| Sales & Mktg Exp. | $8 | $11 | $13 | $11 |
| Other Operating Expenses | $66 | $7 | $1 | $6 |
| Operating Expenses | $93 | $42 | $39 | $41 |
| Operating Income | -$69 | -$13 | -$14 | -$8 |
| % Margin | -132.3% | -20.2% | -22.7% | -11.2% |
| Other Income/Exp. Net | -$4 | $4 | $1 | -$7 |
| Pre-Tax Income | -$73 | -$9 | -$13 | -$16 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$73 | -$9 | -$13 | -$16 |
| % Margin | -139.7% | -14.7% | -21.5% | -21.1% |
| EPS | -1.36 | -0.18 | -0.26 | -0.31 |
| % Growth | -655.6% | 30.8% | 16.1% | – |
| EPS Diluted | -1.36 | -0.18 | -0.26 | -0.31 |
| Weighted Avg Shares Out | 53 | 53 | 52 | 51 |
| Weighted Avg Shares Out Dil | 53 | 53 | 52 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $1 | $1 |
| Interest Expense | $3 | $2 | $2 | $2 |
| Depreciation & Amortization | $6 | $7 | $7 | $7 |
| EBITDA | -$63 | $0 | -$4 | -$7 |
| % Margin | -121.6% | 0% | -6.4% | -9.1% |